What will Brexit mean for pharma companies on both sides of the Atlantic? Given the ‘special relationship’ between the US and UK – and the particular track record of collaboration in the pharma industry – many people within and beyond the industry are trying
MoreBy Justin Kozak, Executive VP & Life Sciences Lead, Founder Shield The tide is turning in the once-booming biotech industry. Funding slowdowns and
MoreSingapore eDevelopment Ltd (SeD) is pleased to announce that its U.S. biomedical subsidiary Global BioLife Inc. has developed 3F Antimicrobial
MoreWhat will Brexit mean for pharma companies on both sides of the Atlantic? Given the ‘special relationship’ between the US
MorebioLIVE – the UBM bioprocessing and manufacturing event opening in October (9-11) in Madrid – announces that it is to
MoreThough vaccines contribute significantly to improving world health by preventing the debilitating, and in some cases, fatal effects of infectious
More